Wanda

Wanda Inc is a remote monitoring, medical analytics, and management company targeting chronic disease primary care patients. The Remote Monitoring System (RMS) transmits data from the patient’s home to the WANDA analytics module, which highlights high-risk cases to clinicians, allowing them to take action before adverse events occur, potentially reducing hospitalization rates. Wanda Inc combines personalized medicine with secure computing and revolutionary data mining and analytics technologies, representing a paradigm shift in modern healthcare. Globally, 75% of all healthcare costs can be attributed to chronic diseases, with heart failure, coronary artery disease, chronic obstructive pulmonary disease, and diabetes being the most costly. In 2010, the U.S. spent 17.6% of its GDP on healthcare, while the UK spent 9.6%. A 2011 report by the World Economic Forum further predicted that without changes in chronic disease management, global healthcare costs by 2030 would lead to cumulative output losses of $47 trillion, approximately 75% of the global GDP in 2010. Wanda Inc is a pioneer in this vast and rapidly growing market. The company is based in Silicon Valley and maintains an ongoing partnership with the UCLA Wireless Health Institute.